Cargando…
Editorial Comment to Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
Autores principales: | Takeuchi, Ario, Shiota, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469818/ https://www.ncbi.nlm.nih.gov/pubmed/32914067 http://dx.doi.org/10.1002/iju5.12181 |
Ejemplares similares
-
Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
por: Maegawa, Yoko, et al.
Publicado: (2020) -
Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
por: Visentin, Andrea, et al.
Publicado: (2021) -
Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021) -
Editorial Comment to Endoscopic laser treatment for urine leakage caused by an isolated calyx after robot‐assisted partial nephrectomy
por: Kobayashi, Satoshi, et al.
Publicado: (2021) -
Editorial Comment to Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
por: Matsumoto, Takashi, et al.
Publicado: (2021)